VX-765 Therapy, Given Through Nose, Limits MS Progression & Fighting Anxiety to Help Others With MS

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how an early study shows that VX-765 therapy, given through the nose, limits MS progression.

Plus, Multiple Sclerosis News Today’s columnist, Jessie Ace, discusses how she fought past her anxiety to create a resource to help others diagnosed with illnesses like MS, despite challenges.

=====================================

Treatment for Relapsing MS Progression | MAYZENT® (siponimod)

Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

=====================================

Are you interested in learning more about multiple sclerosis? If so, please visit:

=====================================

To join in on conversations regarding multiple sclerosis, please visit:

https://multiplesclerosisnewstoday.com/forums/